Trade Evotec AG - EVT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.110 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017263% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004959% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.33 |
| Open | 7.3 |
| 1-Year Change | -22.87% |
| Day's Range | 7.15 - 7.37 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 7.280 | -0.055 | -0.75% | 7.335 | 7.415 | 7.120 |
| Apr 24, 2025 | 7.330 | -0.220 | -2.91% | 7.550 | 7.560 | 6.985 |
| Apr 23, 2025 | 7.185 | 0.170 | 2.42% | 7.015 | 7.335 | 6.905 |
| Apr 22, 2025 | 6.780 | 0.250 | 3.83% | 6.530 | 6.830 | 6.305 |
| Apr 17, 2025 | 6.445 | 0.340 | 5.57% | 6.105 | 6.590 | 5.890 |
| Apr 16, 2025 | 5.805 | 0.000 | 0.00% | 5.805 | 5.870 | 5.660 |
| Apr 15, 2025 | 5.940 | 0.150 | 2.59% | 5.790 | 5.950 | 5.770 |
| Apr 14, 2025 | 5.710 | 0.175 | 3.16% | 5.535 | 5.810 | 5.490 |
| Apr 11, 2025 | 5.290 | -0.240 | -4.34% | 5.530 | 5.530 | 5.200 |
| Apr 10, 2025 | 5.370 | -0.515 | -8.75% | 5.885 | 5.940 | 5.370 |
| Apr 9, 2025 | 5.320 | -0.175 | -3.18% | 5.495 | 5.610 | 5.260 |
| Apr 8, 2025 | 5.675 | 0.225 | 4.13% | 5.450 | 5.760 | 5.250 |
| Apr 7, 2025 | 5.205 | 0.055 | 1.07% | 5.150 | 5.510 | 5.025 |
| Apr 4, 2025 | 5.495 | -0.335 | -5.75% | 5.830 | 5.930 | 5.345 |
| Apr 3, 2025 | 5.895 | 0.145 | 2.52% | 5.750 | 6.070 | 5.740 |
| Apr 2, 2025 | 5.905 | -0.080 | -1.34% | 5.985 | 5.985 | 5.725 |
| Apr 1, 2025 | 6.120 | 0.050 | 0.82% | 6.070 | 6.185 | 5.990 |
| Mar 31, 2025 | 6.040 | 0.135 | 2.29% | 5.905 | 6.070 | 5.740 |
| Mar 28, 2025 | 6.000 | -0.015 | -0.25% | 6.015 | 6.040 | 5.895 |
| Mar 27, 2025 | 6.075 | -0.095 | -1.54% | 6.170 | 6.200 | 5.970 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
About Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.
| Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com